Drugs / amoxicillin/clavulanic acid
Trials 0
| Phase | Registry id | Dates | Indication | Sponsor | Status | Outcome |
|---|---|---|---|---|---|---|
| Comparator or background therapy1 trial | ||||||
| Phase 4 | NCT02057679 Comparator | Feb 2014 → Mar 2017 | acute cholecystitis | Hospital Italiano de Buenos Aires | Completed | No outcome recorded |
Evidence & citations 3 cited values
Every value below carries the sentence it was read from. 2 sources stand behind the page.
| Field | Value | Cited text |
|---|---|---|
| Known as | amoxicillin/clavulanic acid | “either receiving amoxicillin/clavulanic acid or placebo for 5 consecutive days.” PMID 26582405 ↗ Nov 2015 |
| Known as | Amoxicillin clavulanic | “Drug: Amoxicillin clavulanic” NCT02057679 ↗ |
| Route | Oral | “3 g per day divided into 3 oral intakes of 1 g each (2 pill of Amoxicillin Clavulanic every 8 hrs).” NCT02057679 ↗ |